The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Molecular Targets for AIDS Therapy
Abstract
The development of antiretroviral therapy against acquired immunodeficiency syndrome (AIDS) has been an intense research effort since the discovery of the causative agent, human immunodeficiency virus (HIV). A large array of drugs and biologic substances can inhibit HIV replication in vitro. Nucleoside analogs—particularly those belonging to the dideoxynucleoside family—can inhibit reverse transcriptase after anabolic phosphorylation. 3′-Azido-2′,3′-dideoxythymidine (AZT) was the first such drug tested in individuals with AIDS, and considerable knowledge of structure-activity relations has emerged for this class of drugs. However, virtually every step in the replication of HIV could serve as a target for a new therapeutic intervention. In the future, non-nucleoside-type drugs will likely become more important in the experimental therapy of AIDS, and antiretroviral therapy will exert major effects against the morbidity and mortality caused by HIV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Phosphate-Methylated DNA Aimed at HIV-1 RNA Loops and Integrated DNA Inhibits Viral Infectivity
Buck, H. M., Koole, L. H., van Genderen, M. H. P., Smit, L., Geelen, J. L. M. C., Jurriaans, S., & Goudsmit, J. (1990) · Science · doi:10.1126/science.2326635 · Cited by 49
RetractedThe Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Self-citationZamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
Green, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553
Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative Disorders
Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M., Halligan, G., Biberfeld, P., Wong-Staal, F., Kramarsky, B., et al. (1986) · Science · doi:10.1126/science.2876520 · Cited by 1,428
McCune, J., Namikawa, R., Kaneshima, H., Shultz, L., Lieberman, M., & Weissman, I. (1988) · Science · doi:10.1126/science.241.4873.1632 · Cited by 1,406
Furman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., & Mitsuya, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8333 · Cited by 1,347
Self-citationVolberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221401 · Cited by 1,283
Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., & Cullen, B. R. (1989) · Nature · doi:10.1038/338254a0 · Cited by 1,280
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170402 · Cited by 1,199
Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease
Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,168
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,039
Self-citationThe accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997
Kennedy, C. O. (1971) · British Homeopathic Journal · doi:10.1016/s0007-0785(71)80027-3 · Cited by 974
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression
Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., & Varmus, H. E. (1988) · Nature · doi:10.1038/331280a0 · Cited by 966
Fidelity of HIV-1 reverse transcriptase
Preston, B. D., Poiesz, B. J., & Loeb, L. A. (1988) · Science · doi:10.1126/science.2460924 · Cited by 931
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., et al. (1990) · Science · doi:10.1126/science.2183354 · Cited by 929
Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., & Wong-Staal, F. (1990) · Nature · doi:10.1038/345084a0 · Cited by 896
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
Navia, M. A., Fitzgerald, P. M. D., McKeever, B. M., Leu, C.-T., Heimbach, J. C., Herber, W. K., Sigal, I. S., Darke, P. L., & Springer, J. P. (1989) · Nature · doi:10.1038/337615a0 · Cited by 894
Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
Dalakas, M. C., Illa, I., Pezeshkpour, G. H., Laukaitis, J. P., Cohen, B., & Griffin, J. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004193221602 · Cited by 844
Rosen, C. A., Sodroski, J. G., & Haseltine, W. A. (1985) · Cell · doi:10.1016/s0092-8674(85)80062-3 · Cited by 807
Yarchoan, R., Weinhold, K., Lyerly, H. K., Gelmann, E., Blum, R., Shearer, G., Mitsuya, H., Collins, J., Myers, C., Klecker, R., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92808-4 · Cited by 802
Self-citationPotent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Characterization of oligonucleotide transport into living cells.
Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S., & Neckers, L. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3474 · Cited by 734
Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H., & Fauci, A. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2365 · Cited by 712
Activation of the AIDS Retrovirus Promoter by the Cellular Transcription Factor, Sp1
Jones, K. A., Kadonaga, J. T., Luciw, P. A., & Tjian, R. (1986) · Science · doi:10.1126/science.3008338 · Cited by 701
Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson, L., Selk, L., Kent, S. B. H., & Wlodawer, A. (1989) · Science · doi:10.1126/science.2686029 · Cited by 684
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism
Cullen, B. R. (1986) · Cell · doi:10.1016/0092-8674(86)90696-3 · Cited by 681
Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C., & Wong-Staal, F. (1986) · Cell · doi:10.1016/0092-8674(86)90062-0 · Cited by 669
Ribozymes as Potential Anti-HIV-1 Therapeutic Agents
Sarver, N., Cantin, E. M., Chang, P. S., Zaia, J. A., Ladne, P. A., Stephens, D. A., & Rossi, J. J. (1990) · Science · doi:10.1126/science.2107573 · Cited by 658
Cech, T. R., & Bass, B. L. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003123 · Cited by 633
Occurrence of malignancy in immunodeficiency diseases: A literature review
Gatti, R. A., & Good, R. A. (1971) · Cancer · doi:10.1002/1097-0142(197107)28:1<89::aid-cncr2820280117>3.0.co;2-q · Cited by 632
A second post-transcriptional trans-activator gene required for HTLV-III replication
Sodroski, J., Goh, W. C., Rosen, C., Dayton, A., Terwilliger, E., & Haseltine, W. (1986) · Nature · doi:10.1038/321412a0 · Cited by 631
Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T., & Pavlakis, G. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1495 · Cited by 624
Signals for ribosomal frameshifting in the rous sarcoma virus gag-pol region
Jacks, T., Madhani, H. D., Masiarz, F. R., & Varmus, H. E. (1988) · Cell · doi:10.1016/0092-8674(88)90031-1 · Cited by 615
Designing CD4 immunoadhesins for AIDS therapy
Capon, D. J., Chamow, S. M., Mordenti, J., Marsters, S. A., Gregory, T., Mitsuya, H., Byrn, R. A., Lucas, C., Wurm, F. M., Groopman, J. E., et al. (1989) · Nature · doi:10.1038/337525a0 · Cited by 615
Self-citationGruters, R. A., Neefjes, J. J., Tersmette, M., de Goede, R. E. Y., Tulp, A., Huisman, H. G., Miedema, F., & Ploegh, H. L. (1987) · Nature · doi:10.1038/330074a0 · Cited by 578
Aldovini, A., & Young, R. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.1920-1926.1990 · Cited by 546
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
di Marzo Veronese, F., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1986) · Science · doi:10.1126/science.2418504 · Cited by 545
Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J. S., & Broder, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7706 · Cited by 533
Self-citationZagury, D., Bernard, J., Leonard, R., Cheynier, R., Feldman, M., Sarin, P. S., & Gallo, R. C. (1986) · Science · doi:10.1126/science.2418502 · Cited by 530
soluble form of CD4 (T4) protein inhibits AIDS virus infection
Deen, K. C., McDougal, J. S., Inacker, R., Folena-Wasserman, G., Arthos, J., Rosenberg, J., Maddon, P. J., Axel, R., & Sweet, R. W. (1988) · Nature · doi:10.1038/331082a0 · Cited by 527
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice
Vogel, J., Hinrichs, S. H., Reynolds, R. K., Luciw, P. A., & Jay, G. (1988) · Nature · doi:10.1038/335606a0 · Cited by 526
Poli, G., Bressler, P., Kinter, A., Duh, E., Timmer, W. C., Rabson, A., Justement, J. S., Stanley, S., & Fauci, A. S. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.151 · Cited by 512
YARCHOAN, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90283-8 · Cited by 512
Self-citationMechanism of oligonucleotide uptake by cells: involvement of specific receptors?
Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V., & Vlassov, V. V. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6454 · Cited by 509
Sodroski, J., Rosen, C., Wong-Staal, F., Salahuddin, S. Z., Popovic, M., Arya, S., Gallo, R. C., & Haseltine, W. A. (1985) · Science · doi:10.1126/science.2981427 · Cited by 493
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
Self-citationBlocking of HIV-1 Infectivity by a Soluble, Secreted Form of the CD4 Antigen
Smith, D. H., Byrn, R. A., Marsters, S. A., Gregory, T., Groopman, J. E., & Capon, D. J. (1987) · Science · doi:10.1126/science.3500514 · Cited by 485
The HIV A (sor) gene product is essential for virus infectivity
Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., & Martin, M. A. (1987) · Nature · doi:10.1038/328728a0 · Cited by 479
Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., Skinner, M. A., & Valerio, R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.6925 · Cited by 476
Expression of the Rous Sarcoma Virus pol Gene by Ribosomal Frameshifting
Jacks, T., & Varmus, H. E. (1985) · Science · doi:10.1126/science.2416054 · Cited by 469
Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., & De Clercq, E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6132 · Cited by 465
Mitsuya, H., Looney, D. J., Kuno, S., Ueno, R., Wong-Staal, F., & Broder, S. (1988) · Science · doi:10.1126/science.2452480 · Cited by 463
Self-citationTat Protein from Human Immunodeficiency Virus Forms a Metal-Linked Dimer
Frankel, A. D., Bredt, D. S., & Pabo, C. O. (1988) · Science · doi:10.1126/science.2832944 · Cited by 457
Lapatto, R., Blundell, T., Hemmings, A., Overington, J., Wilderspin, A., Wood, S., Merson, J. R., Whittle, P. J., Danley, D. E., Geoghegan, K. F., et al. (1989) · Nature · doi:10.1038/342299a0 · Cited by 456
The Site of Attachment in Human Rhinovirus 14 for Antiviral Agents That Inhibit Uncoating
Smith, T. J., Kremer, M. J., Luo, M., Vriend, G., Arnold, E., Kamer, G., Rossmann, M. G., McKinlay, M. A., Diana, G. D., & Otto, M. J. (1986) · Science · doi:10.1126/science.3018924 · Cited by 455
Pizzo, P. A., Eddy, J., Falloon, J., Balis, F. M., Murphy, R. F., Moss, H., Wolters, P., Brouwers, P., Jarosinski, P., Rubin, M., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810063191401 · Cited by 449
Self-citationHIV infection is blocked in vitro by recombinant soluble CD4
Fisher, R. A., Bertonis, J. M., Meier, W., Johnson, V. A., Costopoulos, D. S., Liu, T., Tizard, R., Walker, B. D., Hirsch, M. S., Schooley, R. T., et al. (1988) · Nature · doi:10.1038/331076a0 · Cited by 446
In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine
Yarchoan, R., Mitsuya, H., Thomas, R. V., Pluda, J. M., Hartman, N. R., Perno, C.-F., Marczyk, K. S., Allain, J.-P., Johns, D. G., & Broder, S. (1989) · Science · doi:10.1126/science.2502840 · Cited by 427
Self-citationA soluble CD4 protein selectively inhibits HIV replication and syncytium formation
Hussey, R. E., Richardson, N. E., Kowalski, M., Brown, N. R., Chang, H.-C., Siliciano, R. F., Dorfman, T., Walker, B., Sodroski, J., & Reinherz, E. L. (1988) · Nature · doi:10.1038/331078a0 · Cited by 427
Clapham, P. R., Weber, J. N., Whitby, D., McIntosh, K., Dalgleish, A. G., Maddon, P. J., Deen, K. C., Sweet, R. W., & Weiss, R. A. (1989) · Nature · doi:10.1038/337368a0 · Cited by 402
Zamecnik, P. C., Goodchild, J., Taguchi, Y., & Sarin, P. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4143 · Cited by 400
Brown, P. O., Bowerman, B., Varmus, H. E., & Bishop, J. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2525 · Cited by 399
Soluble CD4 molecules neutralize human immunodeficiency virus type 1
Traunecker, A., Lüke, W., & Karjalainen, K. (1988) · Nature · doi:10.1038/331084a0 · Cited by 393
Lambert, J. S., Seidlin, M., Reichman, R. C., Plank, C. S., Laverty, M., Morse, G. D., Knupp, C., McLaren, C., Pettinelli, C., Valentine, F. T., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005103221901 · Cited by 390
Sequence-specific RNA binding by the HIV-1 Rev protein
Zapp, M. L., & Green, M. R. (1989) · Nature · doi:10.1038/342714a0 · Cited by 386
Retroviral DNA integration: structure of an integration intermediate
Fujiwara, T., & Mizuuchi, K. (1988) · Cell · doi:10.1016/0092-8674(88)90071-2 · Cited by 385
Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T., Hoshino, H., Javaherian, K., Takatsuki, K., & Putney, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.2107-2114.1988 · Cited by 376
Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine.
Roederer, M., Staal, F. J., Raju, P. A., Ela, S. W., Herzenberg, L. A., & Herzenberg, L. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4884 · Cited by 376
Lever, A., Gottlinger, H., Haseltine, W., & Sodroski, J. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.4085-4087.1989 · Cited by 375
A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation
McQuade, T. J., Tomasselli, A. G., Liu, L., Karacostas, V., Moss, B., Sawyer, T. K., Heinrikson, R. L., & Tarpley, W. G. (1990) · Science · doi:10.1126/science.2405486 · Cited by 374
The sor Gene of HIV-1 Is Required for Efficient Virus Transmission in Vitro
Fisher, A. G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, R. C., & Wong-Staal, F. (1987) · Science · doi:10.1126/science.3497453 · Cited by 357
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
Oates, J. A., Wood, A. J. J., Yarchoan, R., Mitsuya, H., Myers, C. E., & Broder, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211106 · Cited by 353
Self-citationYarchoan, R., Brouwers, P., Robert Spitzer, A., Grafman, J., Safai, B., Perno, C., Larson, S., Berg, G., Fischl, M., Wichman, A., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91968-4 · Cited by 352
Self-citationNucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2
Horwitz, J. P., Chua, J., & Noel, M. (1964) · The Journal of Organic Chemistry · doi:10.1021/jo01030a546 · Cited by 348
Selby, M. J., Bain, E. S., Luciw, P. A., & Peterlin, B. M. (1989) · Genes & Development · doi:10.1101/gad.3.4.547 · Cited by 347
Goodenow, M. M., Huet, T., Saurin, W., Kwok, S., Sninsky, J. J., & Wain–Hobson, S. (1989) · PubMed · Cited by 344
Crystal structure of a retroviral protease proves relationship to aspartic protease family
Miller, M., Jaskólski, M., Rao, J. K. M., Leis, J., & Wlodawer, A. (1989) · Nature · doi:10.1038/337576a0 · Cited by 343
Aminosugar derivatives as potential anti-human immunodeficiency virus agents.
Karpas, A., Fleet, G. W., Dwek, R. A., Petursson, S., Namgoong, S. K., Ramsden, N. G., Jacob, G. S., & Rademacher, T. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9229 · Cited by 338
Recombinant Human Erythropoietin for Patients with AIDS Treated with Zidovudine
Fischl, M., Galpin, J. E., Levine, J. D., Groopman, J. E., Henry, D. H., Kennedy, P., Miles, S., Robbins, W., Starrett, B., Zalusky, R., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222103 · Cited by 338
Walker, B. D., Kowalski, M., Goh, W. C., Kozarsky, K., Krieger, M., Rosen, C., Rohrschneider, L., Haseltine, W. A., & Sodroski, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.8120 · Cited by 337
Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.
Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G., & Haseltine, W. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2071 · Cited by 334
Interferon-α But Not AZT Suppresses HIV Expression in Chronically Infected Cell Lines
Poli, G., Orenstein, J. M., Kinter, A., Folks, T. M., & Fauci, A. S. (1989) · Science · doi:10.1126/science.2470148 · Cited by 328
Ito, M., Baba, M., Sato, A., Pauwels, R., Clercq, E. D., & Shigeta, S. (1987) · Antiviral Research · doi:10.1016/0166-3542(87)90018-0 · Cited by 319
trans-activation of viral enhancers by the hepatitis B virus X protein
Spandau, D. F., & Lee, C. H. (1988) · Journal of Virology · doi:10.1128/jvi.62.2.427-434.1988 · Cited by 315
Site-specific mutagenesis of AIDS virus reverse transcriptase
Larder, B. A., Purifoy, D. J. M., Powell, K. L., & Darby, G. (1987) · Nature · doi:10.1038/327716a0 · Cited by 312
RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO
Ho, D., Rota, T., Kaplan, J., Hartshorn, K., Andrews, C., Schooley, R., & Hirsch, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92144-0 · Cited by 305
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6
Lusso, P., Ensoli, B., Markham, P. D., Ablashi, D. V., Salahuddin, S. Z., Tschachler, E., Wong-Staal, F., & Gallo, R. C. (1989) · Nature · doi:10.1038/337370a0 · Cited by 303
Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus
Mosca, J. D., Bednarik, D. P., Raj, N. B. K., Rosen, C. A., Sodroski, J. G., Haseltine, W. A., & Pitha, P. M. (1987) · Nature · doi:10.1038/325067a0 · Cited by 303
Luciw, P. A., Cheng-Mayer, C., & Levy, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1434 · Cited by 303
Kawakami, K., Scheidereit, C., & Roeder, R. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4700 · Cited by 302
McGrath, M. S., Hwang, K. M., Caldwell, S. E., Gaston, I., Luk, K. C., Wu, P., Ng, V. L., Crowe, S., Daniels, J., & Marsh, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2844 · Cited by 302
Siomi, H., Shida, H., Nam, S. H., Nosaka, T., Maki, M., & Hatanaka, M. (1988) · Cell · doi:10.1016/0092-8674(88)90043-8 · Cited by 299
HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol -Protease
Kramer, R. A., Schaber, M. D., Skalka, A. M., Ganguly, K., Wong-Staal, F., & Reddy, E. P. (1986) · Science · doi:10.1126/science.2420008 · Cited by 287
Perno, C. F., Yarchoan, R., Cooney, D. A., Hartman, N. R., Webb, D. S., Hao, Z., Mitsuya, H., Johns, D. G., & Broder, S. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.933 · Cited by 285
Self-citationRibavirin Antagonizes the Effect of Azidothymidine on HIV Replication
Vogt, M. W., Hartshorn, K. L., Furman, P. A., Chou, T.-C., Fyfe, J. A., Coleman, L. A., Crumpacker, C., Schooley, R. T., & Hirsch, M. S. (1987) · Science · doi:10.1126/science.2435003 · Cited by 279
Functional role of human immunodeficiency virus type 1 vpu.
Terwilliger, E. F., Cohen, E. A., Lu, Y. C., Sodroski, J. G., & Haseltine, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.5163 · Cited by 279
Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein
Strebel, K., Klimkait, T., Maldarelli, F., & Martin, M. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3784-3791.1989 · Cited by 275
Bidirectional Interactions Between Human Immunodeficiency Virus Type 1 and Cytomegalovirus
Skolnik, P. R., Kosloff, B. R., & Hirsch, M. S. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.3.508 · Cited by 271
Balzarini, J. M., Kang, G.-J., Dalal, M., Herdewijn, P. A., Clercq, E. D., Broder, S. W., & Johns, D. G. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13752-8 · Cited by 268
Self-citationPluda, J. M., Yarchoan, R., Jaffe, E. S., Feuerstein, I. M., Solomon, D., Steinberg, S. M., Wyvill, K. M., Raubitschek, A., Katz, D., & Broder, S. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-4-276 · Cited by 267
Self-citationMatsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C. A., Mitsuya, H., Wong-Staal, F., Cohen, J. S., & Broder, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4244 · Cited by 262
Self-citationLack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
Kim, S., Ikeuchi, K., Byrn, R., Groopman, J., & Baltimore, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9544 · Cited by 262
Integration of human immunodeficiency virus type 1 DNA in vitro.
Farnet, C. M., & Haseltine, W. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4164 · Cited by 261
Alternative Mechanisms for Activation of Human Immunodeficiency Virus Enhancer in T Cells
Nabel, G. J., Rice, S. A., Knipe, D. M., & Baltimore, D. (1988) · Science · doi:10.1126/science.2830675 · Cited by 257
POST-PARTUM PULMONARY ŒDEMA ASSOCIATED WITH PREVENTIVE THERAPY FOR PREMATURE LABOUR
Tinga, D. J., Aarnoudse, J. G., Rogge, P., Young, S., & Goodlin, R. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92772-7 · Cited by 257
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
Pauwels, R., Balzarini, J., Schols, D., Baba, M., Desmyter, J., Rosenberg, I., Holy, A., & De Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1025 · Cited by 256
Cooley, T. P., Kunches, L. M., Saunders, C. A., Ritter, J. K., Perkins, C. J., McLaren, C., McCaffrey, R. P., & Liebman, H. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005103221902 · Cited by 251
Hartshorn, K. L., Vogt, M. W., Chou, T. C., Blumberg, R. S., Byington, R., Schooley, R. T., & Hirsch, M. S. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.168 · Cited by 234
Vince, R., Hua, M., Brownell, J., Daluge, S., Lee, F., Shannon, W. M., Lavelle, G. C., Qualls, J., Weislow, O. S., Kiser, R., et al. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80950-1 · Cited by 232
Perno, C. F., Yarchoan, R., Cooney, D. A., Hartman, N. R., Gartner, S., Popovic, M., Hao, Z., Gerrard, T. L., Wilson, Y. A., & Johns, D. G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.3.1111 · Cited by 231
Self-citationHuman immunodeficiency virus type 1 negative factor is a transcriptional silencer.
Niederman, T. M., Thielan, B. J., & Ratner, L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1128 · Cited by 231
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues
Meek, T. D., Lambert, D. M., Dreyer, G. B., Carr, T. J., Tomaszek, T. A., Moore, M. L., Strickler, J. E., Debouck, C., Hyland, L. J., Matthews, T. J., et al. (1990) · Nature · doi:10.1038/343090a0 · Cited by 229
Cheng, Y. C., Dutschman, G. E., Bastow, K. F., Sarngadharan, M. G., & Ting, R. Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61637-0 · Cited by 226
Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R., & Greene, W. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9549 · Cited by 225
Zimmerman, T. P., Mahony, W. B., & Prus, K. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45638-4 · Cited by 222
Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules
Traunecker, A., Schneider, J., Kiefer, H., & Karjalainen, K. (1989) · Nature · doi:10.1038/339068a0 · Cited by 217
Gardner, M. B., & Luciw, P. A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.14.2556312 · Cited by 216
Merigan, T. C., Skowron, G., Bozzette, S. A., Richman, D., Uttamchandani, R., Fischl, M., Schooley, R., Hirsch, M., Soo, W., Pettinelli, C., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-3-189 · Cited by 212
Starnes, M. C., & Cheng, Y. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75738-x · Cited by 210
Agrawal, S., Ikeuchi, T., Sun, D., Sarin, P. S., Konopka, A., Maizel, J., & Zamecnik, P. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7790 · Cited by 210
DEXTRAN SULPHATE, A POTENT ANTI-HIV AGENT IN VITRO HAVING SYNERGISM WITH ZIDOVUDINE
Ueno, R., & Kuno, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90681-7 · Cited by 208
Richman, D. D., Grimes, J. M., & Lagakos, S. W. (1990) · PubMed · Cited by 205
Mitsuya, H., Jarrett, R. F., Matsukura, M., Di Marzo Veronese, F., DeVico, A. L., Sarngadharan, M. G., Johns, D. G., Reitz, M. S., & Broder, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2033 · Cited by 203
Self-citationSuppression of HIV Infection in AZT-Treated SCID-hu Mice
McCune, J. M., Namikawa, R., Shih, C.-C., Rabin, L., & Kaneshima, H. (1990) · Science · doi:10.1126/science.2300816 · Cited by 196
Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro
Baba, M., Nakajima, M., Schols, D., Pauwels, R., Balzarini, J., & De Clercq, E. (1988) · Antiviral Research · doi:10.1016/0166-3542(88)90035-6 · Cited by 192
Schooley, R. T., Merigan, T. C., Gaut, P., Hirsch, M. S., Holodniy, M., Flynn, T., Liu, S., Byington, R. E., Henochowicz, S., Gubish, E., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-4-247 · Cited by 192
Kovacs, J. A., Deyton, L., Davey, R., Falloon, J., Zunich, K., Lee, D., Metcalf, J. A., Bigley, J. W., Sawyer, L. A., Zoon, K. C., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-280 · Cited by 191
Dickson, I. R. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92938-x · Cited by 189
Nakashima, H., Kido, Y., Kobayashi, N., Motoki, Y., Neushul, M., & Yamamoto, N. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.10.1524 · Cited by 188
Garcia, J. A., Harrich, D., Pearson, L., Mitsuyasu, R., & Gaynor, R. B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03181.x · Cited by 187
Majumdar, C., Stein, C. A., Cohen, J. S., Broder, S., & Wilson, S. H. (1989) · Biochemistry · doi:10.1021/bi00429a060 · Cited by 187
Self-citationInhibition of retroviral protease activity by an aspartyl proteinase inhibitor
Katoh, I., Yasunaga, T., Ikawa, Y., & Yoshinaka, Y. (1987) · Nature · doi:10.1038/329654a0 · Cited by 181
Synthesis and biological activity of several amino analogues of thymidine.
Lin, T., & Prusoff, W. H. (1978) · PubMed · Cited by 177
Biological properties of a CD4 immunoadhesin
Byrn, R. A., Mordenti, J., Lucas, C., Smith, D., Marsters, S. A., Johnson, J. S., Cossum, P., Chamow, S. M., Wurm, F. M., Gregory, T., et al. (1990) · Nature · doi:10.1038/344667a0 · Cited by 174
Meek, T. D., Dayton, B. D., Metcalf, B. W., Dreyer, G. B., Strickler, J. E., Gorniak, J. G., Rosenberg, M., Moore, M. L., Magaard, V. W., & Debouck, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.1841 · Cited by 174
Synthesis and biological activity of several amino analogs of thymidine
Lin, T.-S., & Prusoff, W. H. (1978) · Journal of Medicinal Chemistry · doi:10.1021/jm00199a020 · Cited by 172
SEVERELY DISTURBED ADOLESCENTS
(1970) · The Lancet · doi:10.1016/s0140-6736(70)90823-8 · Cited by 171
Baba, M., Pauwels, R., Balzarini, J., Herdewijn, P., De Clercq, E., & Desmyter, J. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.10.1613 · Cited by 162
Larder, B. A., Kemp, S. D., & Purifoy, D. J. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4803 · Cited by 158
Functional Analysis of CAR, the Target Sequence for the Rev Protein of HIV-1
Dayton, E. T., Powell, D. M., & Dayton, A. I. (1989) · Science · doi:10.1126/science.2688093 · Cited by 149
Lenardo, M. J., Kuang, A. A., Gifford, A. M., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8825 · Cited by 147
Human Immunodeficiency Virus: The Eighth Gene
Wong‐Staal, F., Chanda, P. K., & Ghrayeb, J. (1987) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1987.3.33 · Cited by 146
Rich, D. H., Green, J., Toth, M. V., Marshall, G. R., & Kent, S. B. H. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00167a003 · Cited by 142
Abrams, D. I., Kuno, S., Wong, R., Jeffords, K., Nash, M., Molaghan, J. B., Gorter, R., & Ueno, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-3-183 · Cited by 134
Dextran Sulfate Is Poorly Absorbed after Oral Administration
Lorentsen, K. J., Hendrix, C. W., Collins, J. M., Kornhauser, D. M., Petty, B. G., Klecker, R. W., Flexner, C., Eckel, R. H., & Lietman, P. S. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-561 · Cited by 132
Effects of 2′,3′‐dideoxynucleosides on mammalian cells and viruses
Waqar, M. A., Evans, M. J., Manly, K. F., et al. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210218 · Cited by 126
Gatignol, A., Kumar, A., Rabson, A. B., & Jeang, K.-T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7828 · Cited by 126
Deitch, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92858-1 · Cited by 124
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogs
Kim, C. H., Márquez, V. E., Broder, S. E., Mitsuya, H., & Driscoll, J. S. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00388a020 · Cited by 113
Self-citationNosaka, T., Siomi, H., Adachi, Y., Ishibashi, M., Kubota, S., Maki, M., & Hatanaka, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9798 · Cited by 108
Tumors Arising in Organ Transplant Recipients
Penn, I. (1978) · Advances in cancer research · doi:10.1016/s0065-230x(08)60645-4 · Cited by 105
Dedera, D., Hu, W., Vander Heyden, N., & Ratner, L. (1989) · Journal of Virology · doi:10.1128/jvi.63.7.3205-3208.1989 · Cited by 100
Frankel, A. D., Chen, L., Cotter, R. J., & Pabo, C. O. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6297 · Cited by 95
Sommadossi, J., CARLISLE, R., Schinazi, R. F., & Zhou, Z. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.997 · Cited by 87
Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides
Gao, W., Hanes, R. N., Vazquez-Padua, M. A., Stein, C. A., Cohen, J. S., & Cheng, Y. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.808 · Cited by 85
Hayashi, S., Norbeck, D. W., ROSENBROOK, W. J., Fine, R. L., Matsukura, M., PLATTNER, J. J., Broder, S., & Mitsuya, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.287 · Cited by 78
Self-citationHartman, N. R., Johns, D. G., & Mitsuya, H. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.805 · Cited by 75
Self-citationWebb, T. R., Mitsuya, H., & Broder, S. E. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00402a038 · Cited by 72
Self-citationJohnson, V. A., Barlow, M. A., Merrill, D. P., Chou, T., & Hirsch, M. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.6.1059 · Cited by 72
Pediatric AIDS: Problems within Problems
Pizzo, P. A. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.2.316 · Cited by 71
Messenger RNA Transport and HIV rev Regulation
Chang, D. D., & Sharp, P. A. (1990) · Science · doi:10.1126/science.2143313 · Cited by 68
Pal, R., Gallo, R. C., & Sarngadharan, M. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9283 · Cited by 68
Yarchoan, R., Mitsuya, H., Pluda, J. M., Marczyk, K. S., Thomas, R. V., Hartman, N. R., Brouwers, P. Y., Perno, C. F., Allain, J., Johns, D. G., et al. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_5.s522 · Cited by 66
Self-citationJohnson, V. A., Barlow, M. A., Chou, T., Fisher, R. A., Walker, B. D., Hirsch, M., & Schooley, R. T. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.837 · Cited by 61
Shirasaka, T., Murakami, K., Ford, H., Kelley, J. A., YOSHIOKA, H., Kojima, E., Aoki, S., Broder, S., & Mitsuya, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9426 · Cited by 57
Self-citationOverview of the Preclinical Development of an Antiretroviral Drug, 2′,3′-Dideoxyinosine
McGowan, J. J., Tomaszewski, J. E., Cradock, J. C., Hoth, D. F., Grieshaber, C. K., Broder, S. E., & Mitsuya, H. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_5.s513 · Cited by 55
Self-citationBlundell, T. L., & Pearl, L. H. (1989) · Nature · doi:10.1038/337596a0 · Cited by 52
Enhancement of HIV Replication and Giant Cell Formation by Tumor Necrosis Factor
Matsuyama, T., Yoshiyama, H., Hamamoto, Y., Yamamoto, N., Soma, G., Mizuno, D., & Kobayashi, N. (1989) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1989.5.139 · Cited by 52
Eriksson, B., CHU, C. K., & Schinazi, R. F. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1729 · Cited by 50
Hayashi, S., Fine, R. L., Chou, T., Currens, M. J., Broder, S., & Mitsuya, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.82 · Cited by 49
Self-citationInhibition of HIV and virus replication by polysulphated polyxylan
BIESERT, L., Suhartono, H., Winkler, I., Meichsner, C., Helsberg, M., Hewlett, G., Klimetzek, V., Moelling, K., Hd, S., Schrinner, E., et al. (1988) · AIDS · doi:10.1097/00002030-198812000-00007 · Cited by 40
Cited by
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
Zheng, G., Patolsky, F., Cui, Y., Wang, W. U., & Lieber, C. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1138 · Cited by 2,436
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
The Immunopathogenesis of Human Immunodeficiency Virus Infection
Epstein, F. H., Pantaleo, G., Graziosi, C., & Fauci, A. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280508 · Cited by 1,189
Structure-Based Strategies for Drug Design and Discovery
Kuntz, I. D. (1992) · Science · doi:10.1126/science.257.5073.1078 · Cited by 989
Metadata
- Authors
- Mitsuya, H., Yarchoan, R., & Broder, S.
- Venue
- Science
- Published
- 1990-09-28
- Volume
- 249
- Issue
- 4976
- Pages
- 1533-1544
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2072409481
- Cited by
- 732
- References
- 180
- FWCI
- 62.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.